Skip to main content

Want a detailed portfolio tracker?

Foghorn Therapeutics (FHTX) P/E (2020 - 2026)

Foghorn Therapeutics (FHTX) P/E from Dec 31, 2020 to Jul 21, 2026. The TTM Foghorn Therapeutics (FHTX) P/E is -3.90. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Foghorn Therapeutics (FHTX)

YearP/EChange
2026-3.90-4.48%
2025-4.08+46.90%
2024-2.78+6.24%
2023-2.62+7.80%
2022-2.43-71.75%
2021-8.60-76.07%
2020-35.92N/A

Comparison Foghorn Therapeutics (FHTX) P/E with competitors

Foghorn Therapeutics (FHTX) P/E is -3.90.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.04%
NBYStablecoin Development Corp0.00-100.11%
ENLVEnlivex Ltd0.07-101.92%
CHRSCoherus Biosciences Inc0.85-121.75%
FBIOFortress Biotech Inc0.95-124.32%
ORMPOramed Pharmaceuticals Inc1.50-138.52%
AGENAgenus Inc3.01-177.14%
INVAInnoviva Inc3.15-180.84%
VXRTVaxart Inc3.55-190.98%
CRMDCorMedix Inc3.63-193.00%
CVACCureVac N.V.4.45-213.94%
GLPGGalapagos NV4.86-224.53%
SRPTSarepta Therapeutics Inc4.88-225.13%
ABEOAbeona Therapeutics Inc5.39-238.08%
ABUSArbutus Biopharma Corp5.60-243.41%
ZVRAZevra Therapeutics Inc5.89-250.89%
SPROSpero Therapeutics Inc6.23-259.63%
CGENCompugen Ltd6.31-261.82%
RIGLRigel Pharmaceuticals6.87-276.13%
SLXNSilexion Therapeutics Corp7.30-287.00%
OMEROmeros Corporation9.26-337.30%
AUPHAurinia Pharmaceuticals Inc9.58-345.66%
PLXProtalix BioTherapeutics Inc10.89-379.13%
ACADAcadia Pharmaceuticals Inc11.73-400.60%
TBPHTheravance Biopharma Inc12.26-414.28%
ADMAAdma Biologics Inc12.42-418.27%
HRMYHarmony Biosciences Holdings Inc13.82-454.21%
SABSSAB Biotherapeutics Inc14.14-462.31%
NAGENiagen Bioscience Inc14.82-479.79%
INCYIncyte Corp15.82-505.53%
REGNRegeneron Pharmaceuticals Inc15.86-506.40%
PBYIPuma Biotechnology Inc17.32-543.80%
CPRXCatalyst Pharmaceuticals Inc17.44-546.97%
EXELExelixis Inc17.54-549.50%
TGTXTG Therapeutics Inc18.97-586.10%
MDXGMimedx Group Inc20.55-626.76%
XOMAXOMA Royalty Corp22.87-686.29%
ARGXArgen X SE24.30-722.77%
CTMXCytomX Therapeutics Inc24.82-736.18%
XOMAOXOMA Royalty Corp25.34-749.60%
HALOHalozyme Therapeutics Inc25.62-756.75%
XOMAPXOMA Royalty Corp25.67-757.94%
VRTXVertex Pharmaceuticals Inc27.99-817.52%
RPRXRoyalty Pharma plc - Class A28.69-835.28%
SLNOSoleno Therapeutics Inc29.02-843.68%
ASNDAscendis Pharma A/S30.09-871.11%
LGNDLigand Pharmaceuticals Inc - Class B37.91-1071.70%
APLSApellis Pharmaceuticals Inc39.02-1100.13%
BMRNBiomarin Pharmaceutical Inc42.21-1181.91%
KRYSKrystal Biotech Inc45.34-1262.18%
ONCBeiGene Ltd69.54-1882.36%
PHARPharming Group N.V.75.03-2022.94%
TECHBio-Techne Corp101.96-2713.24%
VCELVericel Corp109.92-2917.34%
ALNYAlnylam Pharmaceuticals Inc117.96-3123.50%
GMABGenmab140.29-3695.72%
TLXTelix Pharmaceuticals Ltd162.15-4256.06%
CORTCorcept Therapeutics Inc212.86-5555.64%